Oncolytic viruses get a boost with first FDA-approval recommendation
Elie Dolgin • June 1, 2015
The future of cancer-killing viruses lies in their potential to augment cell and antibody immunotherapies.
Continue reading here.
It took nearly 50 years to work out the identity of a caribou-like fossil first discovered by construction workers.
Language model delivers predictions that rival years of lab work.